Drawing for ABALIFE

USPTO serial 87519655

ABALIFE

Reviewed by CopyMark Law Group

Reg. 5716435Status 704Registered
Filing date
Status date
Registration date
Apr 2, 2019
Examiner
LAWRENCE, SUSAN KASTRINER
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.

Status 704: Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active.

Need help with ABALIFE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

LEIGH ANN LINDQUIST

LEIGH ANN LINDQUIST SUGHRUE MION, PLLC2000 PENNSYLVANIA AVENUE NW, SUITE 9000WAHINGTON, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
001botanical extracts for use in the manufacture of cosmetics, nutritional supplements, food, dietary supplements, pharmaceuticals, nutraceuticals [ ; chemicals for use in science and industry; chemical preparations for use in photography; chemicals for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasticides; unprocessed artificial resins; unprocessed plastics; soil fertilizers; fire-extinguishing compositions; tempering preparations; soldering chemicals; chemicals for preserving foodstuffs; tanning agents for use in the manufacture of leather; adhesives for use in industry ]ACTIVE—
005[ medicinal herbal extracts for medical purposes; plant and herb extracts for pharmaceutical use; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal. dermatological, psychiatric and immune system related diseases and disorders; anti-infective products for veterinary use; sanitary products for medical purposes, namely, sanitary napkins, sanitary pad and sanitary panties; dietetic foods and beverages adapted for medical use; food for babies ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 2, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jul 2, 20258.PRREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED—
Jul 2, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 27, 2025ES8RTEAS SECTION 8 RECEIVED—
Apr 2, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 21, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 2, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 23, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 22, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 19, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 19, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 19, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 16, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 16, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 16, 2018CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 19, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 26, 2018IUAFUSE AMENDMENT FILED—
Jun 26, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 9, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 14, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 14, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 25, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 6, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 3, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 3, 2017DOCKASSIGNED TO EXAMINER—
Aug 14, 2017AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Aug 14, 2017ALIEASSIGNED TO LIE—
Jul 19, 2017PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 14, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 11, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance